Prostate-derived ETS factor improves prognosis and represses proliferation and invasion in hepatocellular carcinoma.
Chen EB, Zhou SL, Pang XG, Yin D, Miao PZ, Yang Y, Chen Q, Zhu K, Gao DM, Liu TS, Wang XY, Shi YH, Wu WZ, Zhou J, Zhou ZJ, Dai Z.
Chen EB, et al. Among authors: yang y.
Oncotarget. 2017 Jan 31;8(32):52488-52500. doi: 10.18632/oncotarget.14924. eCollection 2017 Aug 8.
Oncotarget. 2017.
PMID: 28881746
Free PMC article.